Varney Shawn M, Bebarta Vikhyat S, Pitotti Rebecca L, Vargas Toni E
Wilford Hall Medical Center/Brooke Army Medical Center, San Antonio, TX, USA.
Pediatr Emerg Care. 2012 Sep;28(9):883-5. doi: 10.1097/PEC.0b013e3182676518.
In August 2007, the Food and Drug Administration (FDA) released a public health advisory recommending that over-the-counter cough and cold medications (CCMs) not be used in children younger than 2 years. Our objective was to assess parents' awareness and understanding of the guidelines.
We surveyed caregivers of children younger than 2 years in the emergency department of an urban tertiary care military hospital where civilian patients are also treated. After completing the survey, caregivers received a handout explaining the FDA's recommendations.
Our response rate was 99% (264/265). First-time parents constituted 45% (114/251) of responders. Education level was high school, 21%; some college, 36%; and college graduate, 40%. Thirty-one percent (77/247) were aware of the FDA guidelines. Of these 77, 44 (57%) reported the guidelines indicated CCMs were not safe in children younger than 2 years, and 18 (23%) said CCMs have caused death. Twenty-six percent (68/264) did not give CCMs to their children younger than 2 years, and 40% of these reported it was because of learning about the guidelines; 63% (165/264) reported CCMs were effective, 11% ineffective, and 27% did not know. Fifty-seven percent (151/263) reported CCMs were safe, 12% unsafe, and 31% unsure. Twenty-two percent (31/143) planned to use or continue to use CCMs in their children, 34% did not, 23% not sure, and 21% only if their doctor advised it.
The majority of caregivers were not aware of the FDA guidelines on CCM use in children younger than 2 years. Most thought CCMs were safe and effective.
2007年8月，美国食品药品监督管理局（FDA）发布了一项公共卫生咨询建议，即2岁以下儿童不应使用非处方止咳和感冒药（CCM）。我们的目的是评估家长对该指南的知晓度和理解情况。
我们对一家城市三级护理军队医院急诊科中2岁以下儿童的看护者进行了调查，该医院也收治 civilian 患者。完成调查后，看护者收到了一份解释FDA建议的资料。
我们的回复率为99%（264/265）。首次为人父母者占回复者的45%（114/251）。教育程度为高中的占21%；上过一些大学的占36%；大学毕业的占40%。31%（77/247）知晓FDA指南。在这77人中，44人（57%）报告指南表明CCM对2岁以下儿童不安全，18人（23%）表示CCM曾导致死亡。26%（68/264）不给2岁以下孩子使用CCM，其中40%报告是因为了解到该指南；63%（165/264）报告CCM有效，11%认为无效，27%表示不知道。57%（151/263）报告CCM安全，12%认为不安全，31%不确定。22%（31/143）计划在孩子身上使用或继续使用CCM，34%不打算用，23%不确定，21%仅在医生建议时使用。
大多数看护者不知道FDA关于2岁以下儿童使用CCM的指南。大多数人认为CCM安全且有效。
